Avid Bioservices Inc
NASDAQ:CDMO

Watchlist Manager
Avid Bioservices Inc Logo
Avid Bioservices Inc
NASDAQ:CDMO
Watchlist
Price: 12.49 USD 0.08% Market Closed
Market Cap: $801.1m

ROCE

-9.2%
Current
Declining
by 5.4%
vs 3-y average of -3.8%

Return on Capital Employed (ROCE) measures how efficiently a company uses its capital to generate profit. It shows how much net income is earned for each dollar of capital employed.

ROCE
-9.2%
=
EBIT
$-22.3m
/
Avg Capital Employed
$242.8m

Return on Capital Employed (ROCE) measures how efficiently a company uses its capital to generate profit. It shows how much net income is earned for each dollar of capital employed.

ROCE
-9.2%
=
EBIT
$-22.3m
/
Avg Capital Employed
$242.8m

Peer Comparison

Country Company Market Cap ROCE
US
Avid Bioservices Inc
NASDAQ:CDMO
798.8m USD
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
394.7B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.9B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
175B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.2B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.6B USD
Loading...
AU
CSL Ltd
ASX:CSL
88.6B AUD
Loading...
NL
argenx SE
XBRU:ARGX
44.1B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.5B USD
Loading...

Market Distribution

Lower than 76% of companies in the United States of America
Percentile
24th
Based on 15 630 companies
24th percentile
-9.2%
Low
-1 112 400% — -2.3%
Typical Range
-2.3% — 11.8%
High
11.8% — 334 937.1%
Distribution Statistics
the United States of America
Min -1 112 400%
30th Percentile -2.3%
Median 5.3%
70th Percentile 11.8%
Max 334 937.1%

Avid Bioservices Inc
Glance View

Market Cap
801.1m USD
Industry
Biotechnology

Avid Bioservices, Inc. engages in the commercial manufacturing. The company is headquartered in Tustin, California and currently employs 252 full-time employees. The firm is focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biopharmaceutical products derived from mammalian cell culture. The firm provides a range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. The Company’s services include CGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The firm also provides process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization.

CDMO Intrinsic Value
6.04 USD
Overvaluation 52%
Intrinsic Value
Price
What is Return on Capital Employed?
Return on Capital Employed (ROCE) measures how efficiently a company uses its capital to generate profit. It shows how much net income is earned for each dollar of capital employed.
How is ROCE calculated?

ROCE is calculated by dividing the EBIT by the Avg Capital Employed.

ROCE
-9.2%
=
EBIT
$-22.3m
/
Avg Capital Employed
$242.8m
What is Avid Bioservices Inc's current ROCE?

The current ROCE for Avid Bioservices Inc is -9.2%, which is below its 3-year median of -3.8%.

How has ROCE changed over time?

Over the last 3 years, Avid Bioservices Inc’s ROCE has decreased from 10.8% to -9.2%. During this period, it reached a low of -9.2% on Dec 1, 2024 and a high of 10.8% on Oct 1, 2021.

Back to Top